Catherine Rose Rahilly-Tierney, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholesterol, HDL | 5 | 2012 | 1827 | 1.240 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2018 | 857 | 0.870 |
Why?
|
| Ambulances | 1 | 2021 | 99 | 0.820 |
Why?
|
| Electric Countershock | 1 | 2018 | 515 | 0.530 |
Why?
|
| Risk Reduction Behavior | 2 | 2012 | 1135 | 0.520 |
Why?
|
| Population Surveillance | 1 | 2021 | 2650 | 0.400 |
Why?
|
| Cholesterol, LDL | 2 | 2009 | 2361 | 0.360 |
Why?
|
| Heptanoic Acids | 1 | 2011 | 352 | 0.350 |
Why?
|
| Defibrillators, Implantable | 1 | 2018 | 1405 | 0.350 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 2144 | 0.330 |
Why?
|
| Apolipoprotein E4 | 1 | 2011 | 612 | 0.330 |
Why?
|
| Lipoproteins, HDL | 1 | 2012 | 648 | 0.310 |
Why?
|
| Cardiovascular Diseases | 5 | 2012 | 14438 | 0.290 |
Why?
|
| Coronary Disease | 3 | 2011 | 6150 | 0.270 |
Why?
|
| Aspirin | 2 | 2014 | 3189 | 0.270 |
Why?
|
| Longevity | 1 | 2012 | 1030 | 0.260 |
Why?
|
| Pyrroles | 1 | 2011 | 1172 | 0.250 |
Why?
|
| Hypolipidemic Agents | 1 | 2009 | 617 | 0.250 |
Why?
|
| Physicians | 3 | 2012 | 4375 | 0.250 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2279 | 0.250 |
Why?
|
| Aging | 2 | 2012 | 8349 | 0.220 |
Why?
|
| Veterans | 2 | 2012 | 2238 | 0.220 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7499 | 0.220 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 4014 | 0.200 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4352 | 0.200 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 1867 | 0.190 |
Why?
|
| Overweight | 1 | 2011 | 2272 | 0.190 |
Why?
|
| Thyroid Nodule | 2 | 2017 | 738 | 0.190 |
Why?
|
| Atrial Fibrillation | 2 | 2014 | 4562 | 0.180 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9504 | 0.170 |
Why?
|
| Body Mass Index | 2 | 2012 | 12535 | 0.150 |
Why?
|
| Veterans Health | 1 | 2018 | 197 | 0.150 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3149 | 0.140 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 12460 | 0.140 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 12483 | 0.130 |
Why?
|
| Risk Factors | 10 | 2018 | 70879 | 0.130 |
Why?
|
| Cause of Death | 2 | 2018 | 3612 | 0.130 |
Why?
|
| Thyroid Neoplasms | 2 | 2017 | 2225 | 0.130 |
Why?
|
| Decision Making | 1 | 2008 | 3846 | 0.130 |
Why?
|
| Massachusetts | 2 | 2021 | 8743 | 0.120 |
Why?
|
| Time Factors | 5 | 2018 | 40887 | 0.120 |
Why?
|
| Amplified Fragment Length Polymorphism Analysis | 1 | 2011 | 5 | 0.110 |
Why?
|
| Aged | 11 | 2018 | 162468 | 0.110 |
Why?
|
| Comorbidity | 2 | 2018 | 10435 | 0.100 |
Why?
|
| Thyroid Gland | 1 | 2017 | 1158 | 0.100 |
Why?
|
| United States | 6 | 2018 | 67910 | 0.100 |
Why?
|
| beta Carotene | 1 | 2011 | 519 | 0.100 |
Why?
|
| Equipment Failure | 1 | 2012 | 580 | 0.100 |
Why?
|
| Aged, 80 and over | 7 | 2012 | 58326 | 0.090 |
Why?
|
| Middle Aged | 10 | 2018 | 214666 | 0.090 |
Why?
|
| Age Factors | 3 | 2012 | 18787 | 0.090 |
Why?
|
| Syncope | 1 | 2012 | 434 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2014 | 40032 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2017 | 23476 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 20062 | 0.080 |
Why?
|
| Male | 12 | 2018 | 350352 | 0.080 |
Why?
|
| Humans | 20 | 2021 | 715818 | 0.080 |
Why?
|
| Pacemaker, Artificial | 1 | 2012 | 767 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 13643 | 0.080 |
Why?
|
| Causality | 1 | 2012 | 1180 | 0.070 |
Why?
|
| Patient Admission | 1 | 2012 | 1396 | 0.070 |
Why?
|
| Heterozygote | 1 | 2011 | 2794 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2017 | 3350 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2018 | 72473 | 0.060 |
Why?
|
| Motor Activity | 1 | 2013 | 2774 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2018 | 7901 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2012 | 4312 | 0.060 |
Why?
|
| Anticholesteremic Agents | 1 | 2009 | 960 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2720 | 0.050 |
Why?
|
| Health Surveys | 1 | 2012 | 4036 | 0.050 |
Why?
|
| Linear Models | 1 | 2012 | 5984 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2008 | 1005 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2008 | 2512 | 0.050 |
Why?
|
| Life Style | 1 | 2012 | 3730 | 0.050 |
Why?
|
| Prevalence | 3 | 2017 | 14912 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2012 | 2030 | 0.050 |
Why?
|
| Alleles | 1 | 2011 | 7099 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2011 | 39305 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2018 | 62040 | 0.050 |
Why?
|
| Recurrence | 1 | 2011 | 8240 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 3899 | 0.040 |
Why?
|
| Sex Factors | 1 | 2012 | 10666 | 0.040 |
Why?
|
| Cardiology | 1 | 2008 | 1645 | 0.040 |
Why?
|
| Clavicle | 1 | 1998 | 185 | 0.040 |
Why?
|
| Brachial Plexus | 1 | 1998 | 169 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2008 | 4411 | 0.040 |
Why?
|
| Female | 6 | 2018 | 377229 | 0.040 |
Why?
|
| Survival Rate | 1 | 2011 | 13213 | 0.040 |
Why?
|
| Risk | 1 | 2008 | 9799 | 0.040 |
Why?
|
| Smoking | 1 | 2012 | 8980 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 9596 | 0.030 |
Why?
|
| Adult | 5 | 2012 | 212279 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1999 | 1507 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2017 | 1059 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 23437 | 0.030 |
Why?
|
| Israel | 1 | 2012 | 699 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 51317 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 17409 | 0.020 |
Why?
|
| Stroke | 1 | 2011 | 9507 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 29007 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 1998 | 1876 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 7954 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14902 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2013 | 9985 | 0.010 |
Why?
|
| Endarterectomy | 1 | 1999 | 202 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2011 | 11945 | 0.010 |
Why?
|
| Markov Chains | 1 | 1999 | 985 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 20733 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 1999 | 1627 | 0.010 |
Why?
|
| Heart Failure | 1 | 2012 | 10041 | 0.010 |
Why?
|
| Radiography | 1 | 1998 | 6980 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1999 | 5266 | 0.000 |
Why?
|
| Diagnostic Imaging | 1 | 1999 | 3494 | 0.000 |
Why?
|
| Adolescent | 1 | 2012 | 85157 | 0.000 |
Why?
|
| Models, Statistical | 1 | 1999 | 5065 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1998 | 34430 | 0.000 |
Why?
|